Defining and classifying terminology for medication harm: a call for consensus
The multiplicity in terms and definitions of medication-related harm has been a long-standing challenge for health researchers, clinicians, and regulatory bodies. The purpose of this narrative review was to report the diversity of terms; compare definitions, classifications, and models describing medication harm; and suggest which may be useful in both clinical practice and the research setting.
A narrative review of key studies defining and/or classifying medication harm terminology was undertaken.
This review found that numerous terms are used to describe medication harm, and that there is a lack of consistency in current definitions, classifications, and applications. This lack of consistency applied across clinical jurisdictions and regulatory terminologies. A number of limitations in current definitions and classifications were identified. These included the exclusion of key types of medication harm events, ambiguous wording, and a lack of clarity and consensus on subclassifications. In general, there was some overlap in key models from the literature and these were presented to describe similarities and differences.
Without uniformity quantifying, comparing, combining, or extrapolating medication harm data, such as a rate of harm in a specific population, is a challenge for those involved in medication safety and pharmacovigilance. There is a pressing need for further discussion and international consensus on this topic. Adoption of standard descriptors by practitioner groups, regulatory and policy organisations would foster quality improvement and patient safety.
KeywordsAdverse drug events Adverse drug reactions Medication errors Medication harm Drug-related problems
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 1.Agency for Healthcare Research and Quality. Medication Errors 2017. Available from: https://psnet.ahrq.gov/primers/primer/23/medication-errors
- 8.World Health Organisation. Glossary of Patient Safety Concepts and References 2009Google Scholar
- 13.Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD (1990) Drug-related problems: their structure and function. Drug Intell Clin Pharm 24:1093–1097Google Scholar
- 15.American Society of Health-System Pharmacists (1998) Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events and adverse drug reactions. Am J Health Syst Pharm 55:165–166Google Scholar
- 16.Rawlins M, Thompson JW (1977) Pathogenesis of adverse drug reactions: textbook of adverse drug reactions. Oxford University Press, OxfordGoogle Scholar
- 20.National Coordinating Centre for Medication Error Reporting and Prevention (NCC MERP). Taxonomy for Medication Errors 2005 [cited 2018 5 Jan]. Available from: http://www.nccmerp.org/taxonomy-medication-errors-now-available
- 21.Otero López MJ, Dominguez-Gil A (2000) Adverse drug events: an emerging pathology. Pharm Hosp 24(4):258–266Google Scholar
- 24.The PCNE Classification V 7.0 [Internet]. Pharmaceutical Care Network Europe Foundation. 2016 [cited 19th March 2017]. Available from: http://www.pcne.org/working-groups/2/drug-related-problems
- 26.Canadian Patient Safety Institute. The Economics of Patient Safety in Acute Care - Technical Report 2018. Available from: http://www.patientsafetyinstitute.ca/en/search/pages/results.aspx?k=adverse%20drug%20events
- 27.European Medicines Agency. Question and answer document on the European database of adverse drug reaction reports website London2012. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2012/05/WC500127958.pdf
- 28.International Conference on Harmonisation (ICH). Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting 2003. Available from: http://www.ich.org/home.html
- 29.Institute For Healthcare Improvement (IHI). Adverse Drug Events per 1000 2018. Available from: http://www.ihi.org/resources/Pages/Measures/ADEsper1000Doses.aspx
- 30.Institute for Safe Medication Practices. ISMP Medication Safety Alert! Adverse drug reactions: documentation is important but communication is critical Horsham, PA.2018. Available from: http://www.ismp.org/Newsletters/acutecare/articles/20000906.asp
- 31.Therapeutic Goods Administration. Reporting adverse drug reactions 2014. Available from: https://www.tga.gov.au/publication/reporting-adverse-drug-reactions#whattoreport
- 33.The use of the WHO-UMC system for standardised case causality assessment [Internet]. Uppsala Monitoring Centre. [cited 2 Jan 2018]. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf
- 39.Kohn LT, Corrigan JM, Donaldson MS (1999) To err is human - building a safer health system. National Academy Press, Washington, DCGoogle Scholar
- 40.International Conference on Harmonisation (ICH). Medical Dictionary for Regulatory Activities MedDRA - version 20.0 2017. Available from: https://www.meddra.org/how-to-use/support-documentation?current
- 42.Hepler CD, Strand LM (1990) Oppurtunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533–543Google Scholar